Biomarkers and personalised treatments, diagnosis and prevention, the perfect combination against cancer

37% of all clinical trials being developed in Spain are aimed at treating oncological diseases New drugs are having a direct impact on patient survival, according to the SEOM Tobacco, infections, alcohol, sedentary lifestyles and inadequate diets are responsible for a third of cancers, according to the WHO Every 4 February is World Cancer Day. […]

Biogipuzkoa and Farmaindustria promote a programme to awaken vocations, train in health research and attract talent among young people

More than 80 pupils from five schools learn about the process of getting medicines to patients: from R&D to clinical trials The “Bringing science to schools” programme celebrates its second edition in San Sebastian. Farmaindustria.es More than 80 students from five schools in San Sebastian – Saint Patrick’s English School, Mundaiz Ikastetxea, Ekintza Ikastastola, La […]

Pharmaceutical R&D pays off: 46 new innovative medicines to arrive in 2024

The European Medicines Agency approved a total of 114 medicines last year, 46 of which had a new active substance, seven more than the previous year. Up to 15 of these new medicines are for the treatment of rare diseases. Farmaindustria.es Pharmaceutical companies’ continued investment in research and development of new medicines continues to pay […]

Farmaindustria sets two biomedical research objectives for 2025: consolidate Spain’s leadership in clinical trials and boost translational research

The Coordination Committee of the Technological Platform for Innovative Medicines defines its action plan for 2025 Madrid will host the 18th Annual Conference of Biomedical Research Platforms on 13 May. Farmaindustria.es The Coordination Committee of the Spanish Technological Platform for Innovative Medicines (PTEMI) – a working team made up of 9 representatives from public research […]

More than eight out of 10 clinical trials in Spain are promoted by the pharmaceutical industry.

Our country is the leader in Europe with 930 clinical studies authorised in 2024. 22% of research to find new drugs is aimed at rare diseases and increasingly uses advanced therapies. R&D is one of the pillars of the recently approved Strategy for the Pharmaceutical Industry in Spain, on which pharmaceutical companies are working together […]

Spain, Europe’s leading country in clinical drug research

The Aemps authorised a total of 930 studies last year, making it the European regulatory agency that approved the most clinical trials, ahead of countries such as France and Germany. Larazon.es Drug research has become a new source of national pride in the health sector. Since 2024, we are the leading country in Europe in […]

The global pharmaceutical industry spends almost 30% of its revenues on R&D, amounting to nearly 270 billion euros.

The International Federation of Innovative Pharmaceutical Industry publishes the Facts & Figures 2024 report, which outlines the industry’s contribution globally. In 2023, the industry filed 12,425 international patent applications and by October 2024 had more than 12,700 medicines in various stages of development. The sector employs nearly 75 million people worldwide in direct, indirect and […]

The 10 areas that will be key to the advancement of biomedical innovation in the coming years

Pipeline Innovation Review, carried out by the consultancy firm Iqvia for the European Federation of the Pharmaceutical Industry (Efpia) and Vaccines Europe, covers biomedical research underway in Europe and the main innovations expected in the coming years. The report highlights that 97 new medicines have been approved in Europe so far this year, of which […]

‘Clinical trials in primary care improve patients‘ health’.

Farmaindustria and Levante-EMV hold a meeting with experts to discuss the creation of the ‘ICAP Guide’ of good practices for the promotion of clinical research in Primary Care. levante-emv.com Spain is a leader in clinical trials with medicines, with more than 4,000 studies underway – eight out of ten are promoted by the pharmaceutical industry […]

The Spanish Medicines Agency authorises for the first time in Spain a phase I clinical trial under the accelerated assessment procedure

The trial, which will evaluate a vaccine under clinical investigation by GSK, will be conducted in Phase I units at La Paz, La Princesa and Puerta de Hierro University Hospitals in Madrid, as well as at centres in the United States and Australia. Through this process, clinical trials are evaluated in a maximum of 26 […]